Marktanalyse - Growth Hormone Deficiency Global Clinical Trials Review, H1, 2012
GlobalData
4 / 2012
99 Seiten
| Typ: | Marktanalyse |
| Sprache: | Englisch |
| Regionen: | Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika |
| Verfügbarkeit: | verfügbar |
Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:
Growth Hormone Deficiency Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, 'Growth Hormone Deficiency Global Clinical Trials Review, H1, 2012' provides data on the Growth Hormone Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Growth Hormone Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Growth Hormone Deficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Summary
GlobalData's clinical trial report, 'Growth Hormone Deficiency Global Clinical Trials Review, H1, 2012' provides data on the Growth Hormone Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Growth Hormone Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Growth Hormone Deficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Growth Hormone Deficiency 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Growth Hormone Deficiency 25
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Growth Hormone Deficiency Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Novo Nordisk A/S 35
Clinical Trial Overview of Novo Nordisk A/S 35
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Merck & Co., Inc. 39
Clinical Trial Overview of Merck & Co., Inc. 39
Prolor Biotech, Inc. 40
Clinical Trial Overview of Prolor Biotech, Inc. 40
LG Life Sciences, Ltd 41
Clinical Trial Overview of LG Life Sciences, Ltd 41
EMD Serono, Inc. 42
Clinical Trial Overview of EMD Serono, Inc. 42
Ferring International Center S.A. 43
Clinical Trial Overview of Ferring International Center S.A. 43
Genentech, Inc. 44
Clinical Trial Overview of Genentech, Inc. 44
Althea Technologies, Inc. 45
Clinical Trial Overview of Althea Technologies, Inc. 45
Merck KGaA 46
Clinical Trial Overview of Merck KGaA 46
Ascendis Pharma A/S 47
Clinical Trial Overview of Ascendis Pharma A/S 47
Ferring Pharmaceuticals, Inc. 48
Clinical Trial Overview of Ferring Pharmaceuticals, Inc. 48
Versartis, Inc. 49
Clinical Trial Overview of Versartis, Inc. 49
GeneScience Pharmaceuticals Co., Ltd. 50
Clinical Trial Overview of GeneScience Pharmaceuticals Co., Ltd. 50
Ambrx, Inc. 51
Clinical Trial Overview of Ambrx, Inc. 51
Critical Pharmaceuticals Limited 52
Clinical Trial Overview of Critical Pharmaceuticals Limited 52
HanAll Biopharma Co., Ltd. 53
Clinical Trial Overview of HanAll Biopharma Co., Ltd. 53
AEterna Zentaris Inc. 54
Clinical Trial Overview of AEterna Zentaris Inc. 54
Teva Pharmaceutical Industries Limited 55
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 55
Clinical Trial Overview of Top Universities / Institutes / Hospitals 56
Aarhus University 56
Clinical Trial Overview of Aarhus University 56
Massachusetts General Hospital 57
Clinical Trial Overview of Massachusetts General Hospital 57
The Federico II University 58
Clinical Trial Overview of The Federico II University 58
Columbia University 59
Clinical Trial Overview of Columbia University 59
University Hospital Inselspital, Berne 60
Clinical Trial Overview of University Hospital Inselspital, Berne 60
Oregon Health and Science University 61
Clinical Trial Overview of Oregon Health and Science University 61
The Children's Mercy Hospital 62
Clinical Trial Overview of The Children's Mercy Hospital 62
University of Milan 63
Clinical Trial Overview of University of Milan 63
University of California, Los Angeles 64
Clinical Trial Overview of University of California, Los Angeles 64
Imperial College London 65
Clinical Trial Overview of Imperial College London 65
University of Massachusetts 66
Clinical Trial Overview of University of Massachusetts 66
The University of Texas Health Science Center at San Antonio 67
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 67
University Hospital, Angers 68
Clinical Trial Overview of University Hospital, Angers 68
Medical University of Vienna 69
Clinical Trial Overview of Medical University of Vienna 69
University of Louisville 70
Clinical Trial Overview of University of Louisville 70
University of Pennsylvania 71
Clinical Trial Overview of University of Pennsylvania 71
Beth Israel Deaconess Medical Center 72
Clinical Trial Overview of Beth Israel Deaconess Medical Center 72
Vanderbilt University 73
Clinical Trial Overview of Vanderbilt University 73
Duke University 74
Clinical Trial Overview of Duke University 74
University of California, Davis 75
Clinical Trial Overview of University of California, Davis 75
Five Key Clinical Profiles 76
Appendix 96
Abbreviations 96
Definitions 96
Research Methodology 97
Secondary Research 97
About GlobalData 98
Contact Us 98
Disclaimer 98
Source 99
List of Tables
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Growth Hormone Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
Growth Hormone Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Growth Hormone Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Growth Hormone Deficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
Growth Hormone Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 16
Growth Hormone Deficiency Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Growth Hormone Deficiency Therapeutics Clinical Trials, G7 Countries, 2012* 18
Growth Hormone Deficiency Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Growth Hormone Deficiency Therapeutics Clinical Trials, E7 Countries, 2012* 20
Growth Hormone Deficiency Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Growth Hormone Deficiency Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
Growth Hormone Deficiency Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Growth Hormone Deficiency Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 29
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 31
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 33
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 34
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo Nordisk A/S, 2012* 35
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 37
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 38
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 39
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Prolor Biotech, Inc., 2012* 40
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Life Sciences, Ltd, 2012* 41
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by EMD Serono, Inc., 2012* 42
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2012* 43
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012* 44
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Althea Technologies, Inc., 2012* 45
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2012* 46
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Ascendis Pharma A/S, 2012* 47
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring Pharmaceuticals, Inc., 2012* 48
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Versartis, Inc., 2012* 49
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by GeneScience Pharmaceuticals Co., Ltd., 2012* 50
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Ambrx, Inc., 2012* 51
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Critical Pharmaceuticals Limited, 2012* 52
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by HanAll Biopharma Co., Ltd., 2012* 53
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by AEterna Zentaris Inc., 2012* 54
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2012* 55
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012* 56
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 57
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by The Federico II University, 2012* 58
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2012* 59
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2012* 60
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2012* 61
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Mercy Hospital, 2012* 62
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2012* 63
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012* 64
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012* 65
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2012* 66
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2012* 67
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Angers, 2012* 68
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012* 69
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Louisville, 2012* 70
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2012* 71
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012* 72
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2012* 73
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 74
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2012* 75
List of Figures
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Growth Hormone Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
Growth Hormone Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Growth Hormone Deficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Growth Hormone Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 16
Growth Hormone Deficiency Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Growth Hormone Deficiency Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Growth Hormone Deficiency Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Growth Hormone Deficiency Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Growth Hormone Deficiency Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 29
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 34
GlobalData Methodology 97
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Growth Hormone Deficiency 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Growth Hormone Deficiency 25
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Growth Hormone Deficiency Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Novo Nordisk A/S 35
Clinical Trial Overview of Novo Nordisk A/S 35
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Merck & Co., Inc. 39
Clinical Trial Overview of Merck & Co., Inc. 39
Prolor Biotech, Inc. 40
Clinical Trial Overview of Prolor Biotech, Inc. 40
LG Life Sciences, Ltd 41
Clinical Trial Overview of LG Life Sciences, Ltd 41
EMD Serono, Inc. 42
Clinical Trial Overview of EMD Serono, Inc. 42
Ferring International Center S.A. 43
Clinical Trial Overview of Ferring International Center S.A. 43
Genentech, Inc. 44
Clinical Trial Overview of Genentech, Inc. 44
Althea Technologies, Inc. 45
Clinical Trial Overview of Althea Technologies, Inc. 45
Merck KGaA 46
Clinical Trial Overview of Merck KGaA 46
Ascendis Pharma A/S 47
Clinical Trial Overview of Ascendis Pharma A/S 47
Ferring Pharmaceuticals, Inc. 48
Clinical Trial Overview of Ferring Pharmaceuticals, Inc. 48
Versartis, Inc. 49
Clinical Trial Overview of Versartis, Inc. 49
GeneScience Pharmaceuticals Co., Ltd. 50
Clinical Trial Overview of GeneScience Pharmaceuticals Co., Ltd. 50
Ambrx, Inc. 51
Clinical Trial Overview of Ambrx, Inc. 51
Critical Pharmaceuticals Limited 52
Clinical Trial Overview of Critical Pharmaceuticals Limited 52
HanAll Biopharma Co., Ltd. 53
Clinical Trial Overview of HanAll Biopharma Co., Ltd. 53
AEterna Zentaris Inc. 54
Clinical Trial Overview of AEterna Zentaris Inc. 54
Teva Pharmaceutical Industries Limited 55
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 55
Clinical Trial Overview of Top Universities / Institutes / Hospitals 56
Aarhus University 56
Clinical Trial Overview of Aarhus University 56
Massachusetts General Hospital 57
Clinical Trial Overview of Massachusetts General Hospital 57
The Federico II University 58
Clinical Trial Overview of The Federico II University 58
Columbia University 59
Clinical Trial Overview of Columbia University 59
University Hospital Inselspital, Berne 60
Clinical Trial Overview of University Hospital Inselspital, Berne 60
Oregon Health and Science University 61
Clinical Trial Overview of Oregon Health and Science University 61
The Children's Mercy Hospital 62
Clinical Trial Overview of The Children's Mercy Hospital 62
University of Milan 63
Clinical Trial Overview of University of Milan 63
University of California, Los Angeles 64
Clinical Trial Overview of University of California, Los Angeles 64
Imperial College London 65
Clinical Trial Overview of Imperial College London 65
University of Massachusetts 66
Clinical Trial Overview of University of Massachusetts 66
The University of Texas Health Science Center at San Antonio 67
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 67
University Hospital, Angers 68
Clinical Trial Overview of University Hospital, Angers 68
Medical University of Vienna 69
Clinical Trial Overview of Medical University of Vienna 69
University of Louisville 70
Clinical Trial Overview of University of Louisville 70
University of Pennsylvania 71
Clinical Trial Overview of University of Pennsylvania 71
Beth Israel Deaconess Medical Center 72
Clinical Trial Overview of Beth Israel Deaconess Medical Center 72
Vanderbilt University 73
Clinical Trial Overview of Vanderbilt University 73
Duke University 74
Clinical Trial Overview of Duke University 74
University of California, Davis 75
Clinical Trial Overview of University of California, Davis 75
Five Key Clinical Profiles 76
Appendix 96
Abbreviations 96
Definitions 96
Research Methodology 97
Secondary Research 97
About GlobalData 98
Contact Us 98
Disclaimer 98
Source 99
List of Tables
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Growth Hormone Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
Growth Hormone Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Growth Hormone Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Growth Hormone Deficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
Growth Hormone Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 16
Growth Hormone Deficiency Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Growth Hormone Deficiency Therapeutics Clinical Trials, G7 Countries, 2012* 18
Growth Hormone Deficiency Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Growth Hormone Deficiency Therapeutics Clinical Trials, E7 Countries, 2012* 20
Growth Hormone Deficiency Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Growth Hormone Deficiency Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
Growth Hormone Deficiency Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Growth Hormone Deficiency Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 29
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 31
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 33
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 34
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo Nordisk A/S, 2012* 35
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 37
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 38
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 39
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Prolor Biotech, Inc., 2012* 40
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Life Sciences, Ltd, 2012* 41
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by EMD Serono, Inc., 2012* 42
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2012* 43
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012* 44
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Althea Technologies, Inc., 2012* 45
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2012* 46
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Ascendis Pharma A/S, 2012* 47
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring Pharmaceuticals, Inc., 2012* 48
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Versartis, Inc., 2012* 49
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by GeneScience Pharmaceuticals Co., Ltd., 2012* 50
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Ambrx, Inc., 2012* 51
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Critical Pharmaceuticals Limited, 2012* 52
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by HanAll Biopharma Co., Ltd., 2012* 53
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by AEterna Zentaris Inc., 2012* 54
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2012* 55
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012* 56
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 57
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by The Federico II University, 2012* 58
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2012* 59
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2012* 60
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2012* 61
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Mercy Hospital, 2012* 62
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2012* 63
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012* 64
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012* 65
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2012* 66
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2012* 67
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Angers, 2012* 68
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012* 69
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Louisville, 2012* 70
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2012* 71
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012* 72
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2012* 73
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 74
Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2012* 75
List of Figures
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Growth Hormone Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
Growth Hormone Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Growth Hormone Deficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Growth Hormone Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 16
Growth Hormone Deficiency Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Growth Hormone Deficiency Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Growth Hormone Deficiency Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Growth Hormone Deficiency Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Growth Hormone Deficiency Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 29
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32
Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 34
GlobalData Methodology 97
- Growth Hormone Deficiency – Pipeline Review, H1 2013
- Chronic Kidney Disease (Chronic Renal Failure) – Pipeline Review, H1 2013
- Growth Disorders – Pipeline Review, H1 2013
- Kidney Fibrosis – Pipeline Review, H1 2013
- Urinary Incontinence – Pipeline Review, H1 2013
- Global Endocrinology Drugs Market 2012-2016
- Inguinal Hernia Global Clinical Trials Review, H1, 2013
- End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) – Pipeline Review, H2 2012
- Microalbuminuria – Pipeline Review, H2 2012
- Nocturia – Pipeline Review, H2 2012
- Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2012
- Hypoparathyroidism – Pipeline Review, H2 2012
- Proteinuria – Pipeline Review, H2 2012
- Thyroid Gland Disorders – Pipeline Review, H2 2012
- Acute Renal Failure (ARF) (Acute Kidney Injury) – Pipeline Review, H2 2012
- Hypothyroidism Global Clinical Trials Review, H2, 2012
- Interstitial Cystitis (Painful Bladder Syndrome) – Pipeline Review, H2 2012
- Other Genito Urinary Disorders – Pipeline Review, H2 2012
- Urinary Retention Global Clinical Trials Review, H2, 2012
- Focal Segmental Glomerulosclerosis (FSGS) – Pipeline Review, H2 2012
*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.
Hinweise: **The report can be shared by users within one office (one geographical location)
***Across Geographical locations (by the purchasing company only)
Für Sie protokollierte Studien / Marktanalysen:
zuletzt angesehene Studien:
Seite drucken
Seite empfehlen
Home | Werbung | Über marktforschung.de | AGB | Impressum | Sitemap | Suche © 2006 bis 2013 Alle Rechte bei marktforschung.de - Studie - Growth Hormone Deficiency Global Clinical Trials Review, H1, 2012 - Marktdaten / Marktanalysen bei marktforschung.de
